Pathological Functions of LRRK2 in Parkinson’s Disease
Mutations in the gene encoding leucine-rich repeat kinase 2 (LRRK2) are common genetic risk factors for both familial and sporadic Parkinson’s disease (PD). Pathogenic mutations in LRRK2 have been shown to induce changes in its activity, and abnormal increase in LRRK2 kinase activity is thought to c...
Main Authors: | Ga Ram Jeong, Byoung Dae Lee |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2020-11-01
|
Series: | Cells |
Subjects: | |
Online Access: | https://www.mdpi.com/2073-4409/9/12/2565 |
Similar Items
-
LRRK2 and α-Synuclein: Distinct or Synergistic Players in Parkinson’s Disease?
by: Darren M. O’Hara, et al.
Published: (2020-06-01) -
LRRK2 and Protein Aggregation in Parkinson’s Disease: Insights From Animal Models
by: Dylan J. Dues, et al.
Published: (2020-07-01) -
LRRK2-Related Parkinson’s Disease Due to Altered Endolysosomal Biology With Variable Lewy Body Pathology: A Hypothesis
by: Pilar Rivero-Ríos, et al.
Published: (2020-06-01) -
The industrial solvent trichloroethylene induces LRRK2 kinase activity and dopaminergic neurodegeneration in a rat model of Parkinson's disease
by: Briana R. De Miranda, et al.
Published: (2021-06-01) -
From Synaptic Dysfunction to Neuroprotective Strategies in Genetic Parkinson’s Disease: Lessons From LRRK2
by: Andrea Mancini, et al.
Published: (2020-07-01)